explore -WSS

explore

author：hotspot 2025-10-01 21:37:15 - browse：1178

Adam's take main illustration — Molly Ferguson/STAT

Cytokinetics was founded 26 years ago but has not yet developed a drug successfully to approval. That makes Tuesday’s Food and Drug Administration decision on its treatment for heart failure a big deal — except nearly everyone, even investors who own Cytokinetics — hopes the agency rules against it.

Hoping the FDA rejects the Cytokinetics drug, called omecamtiv mecarbil, is a relatively uncommon, up-is-down, down-is-up situation, but it makes sense in this case because the business and science of the drug are not aligned.

Consider: Cytokinetics shares rose in December when an outside group of experts convened by the FDA to examine omecamtiv’s benefits and risks recommended against the medicine’s approval. On Tuesday, the FDA is most likely to heed that advice and turn down the company’s marketing application.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Class action alleges UnitedHealth concealed DOJ probe

hotspot

WSS

Welsh Carson private equity firm escapes from FTC antitrust case

Novel spinal cord stimulator treats paralysis without surgery

Class action alleges UnitedHealth concealed DOJ probe

Sepsis can kill a child within hours. Here's how hospitals are fighting back

Is it ever OK for doctors to lie to their patients?

HHS's proposed rule does nothing to address the climate crisis

focus

explore

focus

As demand for Covid shots wanes, Moderna seeks its next success

Most antidepressants don't work on kids, teens, study finds

In age of alternative facts, a scholarly course on calling out crap

Brain technologies pose threats that are all too real, experts warn

Medical leaders decry Supreme Court decision on affirmative action

Class action alleges UnitedHealth concealed DOJ probe

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Primary care doctor shortage won't be solved by free med school tuition

Jerome Adams on the need for new antivirals for Covid

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

leisure time

Primary care doctor shortage won't be solved by free med school tuition

RSV shot was 90% effective at preventing hospitalizations in kids

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

NEJM study link tiny plastics in blood vessels to heart problems

Crowdfunding for medical bills sidesteps core problem, author says

Novo Nordisk obesity pill bests Wegovy in early trial

explore

hotspot

Wikipedia

focus